Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating the Efficacy of the Parent Support Program (PSP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04531761
Recruitment Status : Not yet recruiting
First Posted : August 28, 2020
Last Update Posted : August 28, 2020
Sponsor:
Collaborator:
American Psychological Foundation
Information provided by (Responsible Party):
Em Matsuno, Palo Alto University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The objective of the study is to evaluate the efficacy of an online intervention (the Parents Support Program) aimed at increasing supportive behaviors among parents of transgender youth. The intervention consists of three modules that include a variety engaging activities such as social perspective taking exercises, writing prompts, videos of parents, youth, and experts, and psycho-educational materials. The study uses an experimental design with a waitlist control. Both the experimental and control groups will complete a pre-test, one month follow up, and two month follow up survey. Targeted outcomes include knowledge about gender diversity, attitudes about trans youth, and supportive parenting behaviors.

Condition or disease Intervention/treatment Phase
Prejudice Gender Identity Knowledge, Attitudes, Practice Behavioral: Parent Support Program Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 400 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Evaluating the Efficacy of the Parent Support Program
Estimated Study Start Date : September 2020
Estimated Primary Completion Date : January 2021
Estimated Study Completion Date : March 2021
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Immediate Access to Parent Support Program Behavioral: Parent Support Program
The parent support program includes three modules aimed at increasing knowledge, positive attitudes, and supportive behaviors towards trans youth. Each online module includes several activities including writing prompts, videos, interactive quizzes, and other educational activities.
No Intervention: Waitlist Control


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Trans-supportive behaviors scale [ Time Frame: One month ]
    This 20 item questionnaire measures the frequency of supportive behaviors enacted in the past month. Response options ranged from 1 (never) to 5 (frequently) based on item anchors from the Ryan et al. (2010) measure on family acceptance. The original 25-item scale was reduced to 20 items based on achieving adequate internal consistency reliability in a previous study with parents of trans youth (Matsuno & Israel, in preparation). An example item is: "I told my child I respect and support them." The measure showed adequate internal consistency reliability in the pilot study of the Parent Support Program (α = .8).


Secondary Outcome Measures :
  1. Attitudes Toward Trans Youth Scale (ATTYS - Birnkrant, 2018) [ Time Frame: One month ]
    Two subscales of the original scale were used consisting of 27 items- Genderism, and Fabricated Identity. The scale had strong reliablity α = .98 and demonstrated convergent and discriminant validity.

  2. Objective knowledge about gender diversity [ Time Frame: One month ]
    The author created a 18-item measure designed to test knowledge about constructs of gender and experiences of transgender people. The items are based on the program content and through best practices for creating multiple choice questions.

  3. Subjective knowledge about gender diversity [ Time Frame: One month ]
    Participants perceptions of their own level knowledge regarding gender diversity will be measured using a 100-point Likert scale from 1 - not at all knowledgeable to 100- extremely knowledgeable. Participants will be asked to rate their perceived knowledge in the following areas: gender terminology, etiology, medical intervention, and impact of parental acceptance.

  4. Self-compassion [ Time Frame: One month ]
    Self-compassion was measured by adapting the self-kindness subscale of the Self-Compassion Scale - Short Form (SCS-SF) (Raes, Pommier, Neff, & Van Gucht, 2011). The subscale demonstrated adequate reliability in a previous sample (α = .78) (Raes et al., 2011). The five items were adapted by adding "as a parent of a trans/non-binary child" at the end of each item to measure self-compassion related to parenting a trans child. Items were rated on a 5-point Likert scale ranging from 1 (almost never) to 5 (almost always). The measure showed strong internal consistency reliability in the pilot study of the Parent Support Program (α = .94).


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Must be 18 years of age or older.
  • Must live in the United States.
  • Must be comfortable communicating in English.
  • Must be a parent of a trans child between the ages of 10 - 24.

Exclusion Criteria:

  • Participants who participated in pilot study or focus groups related to this project.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04531761


Contacts
Layout table for location contacts
Contact: Em Matsuno, PhD 307-460-1395 ematsuno@paloaltou.edu

Locations
Layout table for location information
United States, California
Palo Alto University
Palo Alto, California, United States, 94304
Contact: Em Matsuno, PhD       ematsuno@paloaltou.edu   
Sponsors and Collaborators
Palo Alto University
American Psychological Foundation
Investigators
Layout table for investigator information
Principal Investigator: Em Matsuno, PhD Palo Alto University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Em Matsuno, Postdoctoral Fellow, Palo Alto University
ClinicalTrials.gov Identifier: NCT04531761    
Other Study ID Numbers: 2019-116
First Posted: August 28, 2020    Key Record Dates
Last Update Posted: August 28, 2020
Last Verified: August 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No IPD will be shared with other researchers.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Em Matsuno, Palo Alto University:
transgender
trans youth
parental acceptance
parental support
LGBTQ